Katelynn M Wilton, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Erectile Dysfunction | 2 | 2021 | 444 | 1.130 |
Why?
|
Arthritis, Psoriatic | 2 | 2020 | 219 | 1.020 |
Why?
|
Killer Cells, Natural | 4 | 2020 | 2201 | 0.860 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2020 | 1351 | 0.770 |
Why?
|
Cytoplasmic Granules | 2 | 2020 | 574 | 0.670 |
Why?
|
GRB2 Adaptor Protein | 1 | 2019 | 101 | 0.660 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2019 | 91 | 0.660 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 95 | 0.650 |
Why?
|
Cell Adhesion Molecules | 2 | 2019 | 1601 | 0.510 |
Why?
|
Arthritis, Rheumatoid | 2 | 2021 | 3763 | 0.440 |
Why?
|
Microfilament Proteins | 1 | 2018 | 1134 | 0.430 |
Why?
|
Receptors, Immunologic | 1 | 2019 | 1410 | 0.420 |
Why?
|
Actins | 2 | 2020 | 2050 | 0.420 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1651 | 0.410 |
Why?
|
Lymphocyte Activation | 2 | 2019 | 5485 | 0.370 |
Why?
|
Phosphoproteins | 1 | 2018 | 2448 | 0.330 |
Why?
|
Vascular Diseases | 1 | 2017 | 1161 | 0.320 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 1875 | 0.230 |
Why?
|
Septins | 1 | 2020 | 49 | 0.180 |
Why?
|
Incidence | 4 | 2021 | 21355 | 0.180 |
Why?
|
Cell Transformation, Viral | 2 | 2012 | 526 | 0.170 |
Why?
|
Amyloidosis, Familial | 1 | 2019 | 16 | 0.170 |
Why?
|
Human papillomavirus 16 | 2 | 2012 | 267 | 0.170 |
Why?
|
Skin Diseases, Genetic | 1 | 2019 | 49 | 0.160 |
Why?
|
Pigmentation Disorders | 1 | 2019 | 105 | 0.160 |
Why?
|
Microtubule-Organizing Center | 1 | 2018 | 25 | 0.160 |
Why?
|
Codon, Nonsense | 1 | 2020 | 285 | 0.160 |
Why?
|
Rheumatoid Factor | 1 | 2017 | 185 | 0.140 |
Why?
|
Poisson Distribution | 1 | 2017 | 504 | 0.130 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2019 | 386 | 0.130 |
Why?
|
Cytoskeleton | 1 | 2020 | 1170 | 0.130 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 799 | 0.120 |
Why?
|
Homozygote | 1 | 2020 | 1776 | 0.120 |
Why?
|
Papillomavirus E7 Proteins | 2 | 2012 | 109 | 0.120 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15502 | 0.120 |
Why?
|
Microtubules | 1 | 2020 | 1074 | 0.120 |
Why?
|
Thymus Gland | 1 | 2019 | 1243 | 0.110 |
Why?
|
Behavioral Research | 1 | 2013 | 52 | 0.110 |
Why?
|
Forelimb | 1 | 2013 | 116 | 0.110 |
Why?
|
Oncogene Proteins, Viral | 2 | 2012 | 340 | 0.110 |
Why?
|
Cohort Studies | 4 | 2021 | 41495 | 0.110 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3415 | 0.090 |
Why?
|
Hand Strength | 1 | 2013 | 456 | 0.090 |
Why?
|
Vision, Ocular | 1 | 2013 | 455 | 0.090 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 918 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2017 | 2161 | 0.070 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1373 | 0.070 |
Why?
|
Neoplasms | 1 | 2016 | 22173 | 0.070 |
Why?
|
Protein Binding | 1 | 2019 | 9353 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6484 | 0.070 |
Why?
|
Proteomics | 1 | 2019 | 3848 | 0.060 |
Why?
|
Male | 7 | 2021 | 360846 | 0.060 |
Why?
|
Quinazolines | 1 | 2011 | 1371 | 0.060 |
Why?
|
Humans | 12 | 2021 | 761596 | 0.060 |
Why?
|
Risk | 1 | 2016 | 9610 | 0.060 |
Why?
|
Down-Regulation | 1 | 2011 | 2919 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2012 | 2986 | 0.060 |
Why?
|
Prevalence | 1 | 2020 | 15733 | 0.050 |
Why?
|
NF-kappa B | 1 | 2012 | 2490 | 0.050 |
Why?
|
Software | 1 | 2017 | 4434 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12463 | 0.050 |
Why?
|
Comorbidity | 1 | 2017 | 10508 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 16990 | 0.050 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.050 |
Why?
|
Risk Factors | 2 | 2021 | 74213 | 0.050 |
Why?
|
Qa-SNARE Proteins | 1 | 2020 | 52 | 0.050 |
Why?
|
Signal Transduction | 3 | 2019 | 23447 | 0.050 |
Why?
|
Adult | 4 | 2020 | 221210 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2017 | 9001 | 0.040 |
Why?
|
Papillomavirus Infections | 1 | 2011 | 1613 | 0.040 |
Why?
|
Theilovirus | 1 | 2019 | 11 | 0.040 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2011 | 2020 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10002 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 642 | 0.040 |
Why?
|
Cervix Uteri | 2 | 2012 | 570 | 0.040 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2017 | 94 | 0.040 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2019 | 242 | 0.040 |
Why?
|
Total Lung Capacity | 1 | 2017 | 149 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2020 | 569 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39106 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2011 | 5672 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 2019 | 1519 | 0.030 |
Why?
|
Myositis | 1 | 2017 | 271 | 0.030 |
Why?
|
Middle Aged | 3 | 2017 | 220921 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2017 | 547 | 0.030 |
Why?
|
Cell Communication | 1 | 2020 | 1657 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 1682 | 0.030 |
Why?
|
Foreskin | 1 | 2012 | 33 | 0.020 |
Why?
|
Female | 5 | 2017 | 392705 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2017 | 80647 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2046 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2011 | 439 | 0.020 |
Why?
|
Aged | 2 | 2017 | 169310 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9542 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2013 | 1878 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4062 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2011 | 6131 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2019 | 11530 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 22174 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2012 | 3677 | 0.010 |
Why?
|
Mice | 2 | 2019 | 81539 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2012 | 18966 | 0.010 |
Why?
|
Apoptosis | 1 | 2011 | 9490 | 0.010 |
Why?
|
Animals | 2 | 2019 | 168475 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20568 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11904 | 0.010 |
Why?
|